Sort   by:  
 Page size 
Over 95% of pancreatic ductal adenocarcinomas (PDAC) harbor oncogenic mutations in K-Ras. Upon treatment with K-Ras inhibitors, PDAC cancer cells undergo metabolic reprogramming towards an oxidative phosphorylation-dependent, drug-resistant state. However, direct inhibition of complex I is poorly ...
ORGANISM(S): Homo sapiens (Human) 
2025-07-15 | PXD052360 | Pride
Sort   by:  
 Page size